References
- Paparella MM, Morizono T, Le CT, Mancini F, Sipilä P, Choo YB, et al. Sensorineural hearing loss in otitis media. Ann Otol Rhinol Laryngol 1984; 93: 623–9
- Erkan M, Aslan T, Sevuku E, Guney E. Bacteriology of chronic suppurative otitis media. Ann Otol Rhinol Laryngol 1994; 103: 771–4
- Ogaard AR, Cryz S, Jr, Berdal BP. Exotoxin A from various Pseudomonas aeruginosa cultures: in vivo activity measured by enzyme-linked immunosorbent assay (ELISA). Acta Pathol Microbiol Immunol Scand 1985; 93: 217–23
- Pollack M. Special role of Pseudomonas aeruginosa in chronic suppurative otitis media. Ann Otol Rhinol Laryngol Suppl 1988; 131: 10–3
- Lundman L, Santi PA, Morizono T, Harada T, Juhn SK, Bagger-Sjöbäck D. Inner ear damage and passage through the round window membrane of Pseudomonas aeruginosa Exotoxin A in a chinchilla model. Ann Otol Rhinol Laryngol 1992; 101: 437–44
- Stenqvist M, Anniko M, Pettersson Å. Effect of Pseudomonas aeruginosa Exotoxin A on inner ear function. Acta Otolaryngol (Stockh) 1997; 117: 73–9
- Amaee FR, Comis SD, Osborne MP. NG-Methyl-L-arginine protects the guinea pig cochlea from the cytotoxic effects of pneumolysine. Acta Otolaryngol (Stockh) 1995; 115: 386–91
- Takumida M, Anniko M, Popa R. Possible involvement of free radicals in lipopolysaccharide-induced labyrinthitis in the guinea pig: a morphological and functional investigation. ORL J Otorhinolaryngol Relat Spec 1998; 60: 246–53
- Takumida M, Anniko M, Popa R. Lipopolysaccharide-induced expression of inducible nitric oxide synthase in the guinea pig organ of Corti. Hear Res 2000; 140: 91–8
- Popa R, Anniko M, Takumida M. Otoprotectant minimizes hearing defects caused by Pseudomonas aeruginosa exotoxin A. Acta Otolaryngol 2000; 120: 350–8
- Takumida M, Anniko M, Popa R, Zhang DM. Pharmacological models for inner ear therapy with emphasis on nitric oxide. Acta Otolaryngol 2001; 121: 16–20
- Takumida M, Anniko M. Nitric oxide in the inner ear. Curr Opin Neurol 2002; 15: 11–15
- Kaygusuz I, Ozturk A, Ustundag B, Yalcin S. Role of free oxygen radicals in noise-related hearing impairment. Hear Res 2001; 162: 43–7
- Yamasoba T, Schacht J, Shoji F, Miller JM. Attenuation of cochlear damage from noise trauma by an iron chelator, a free radical scavenger and glial cell line-derived neurotrophic factor in vivo. Brain Res 1999; 815: 317–25
- Sha S-H, Schacht J. Antioxidants attenuate gentamicin-induced free-radical formation in vitro and ototoxicity in vivo: D-methionine is a potent protectant. Hear Res 2000; 142: 34–40
- Tabuchi K, Tsuji S, Ito Z, Hara A, Kusakari J. Does xanthine oxidase contribute to the hydroxyl radical generation in ischemia and reperfusion of the cochlea?. Hear Res 2001; 153: 1–6
- Yamamoto T, Yuki S, Watanabe T, Mitsuka M, Saito K, Kogure K. Delayed neuronal death prevented by inhibition of increased hydroxyradical formation in a transient cerebral ischemia. Brain Res 1997; 762: 240–2
- Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003; 15: 222–9
- Watanabe T, Morita I, Nishi H, Murota S. Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial injury in vitro. Prostaglandins. Leukot Essent Fatty Acids 1998; 33: 81–7
- Takemoto T, Sugahara K, Okuda T, Shimogori H, Yamashita H. The clinical free radical scavenger, edaravone, protects cochlear hair cells from acoustic trauma. Eur J Pharmacol 2004; 487: 113–6
- Horiike O, Shimogori H, Ikeda T, Yamashita H. Protective effect of edaravone against streptomycin-induced vestibulotoxicity in the guinea pig. Eur J Pharmacol 2003; 464: 75–8
- Horiike O, Shimogori H, Yamashita H. Effect of edaravone on streptomycin-induced vestibulotoxicity in the guinea pig. Laryngoscope 2004; 114: 1630–2
- Maetani T, Hakuba N, Taniguchi M, Hyodo J, Shimizu Y, Gyo K. Free radical scavenger protects against inner hair cell loss after cochlear ischemia. Neuroreport 2003; 14: 1881–4